The Broadest Liver In Vitro Model Portfolio in the Marketplace
Carol Tomaszewski2022-01-10T11:11:39-05:00Over the last several years, Visikol has worked to build out its liver cell culture capabilities from solely [...]
Over the last several years, Visikol has worked to build out its liver cell culture capabilities from solely [...]
Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation, cell injury and fibrosis. Progression of this [...]
Drug-induced liver injury (DILI) is one of the most frequent causes of safety-related drug marketing withdrawal, according to the [...]
[contact-form-7 id=”6190″ title=”Request Quote Form”]